Watch for the First Oral GLP-1 Agonist, Rybelsus, During Transitions of Care
November 2019
Semaglutide (Rybelsus, reh-BEL-sus) will be the first ORAL GLP-1 agonist for type 2 diabetes...it's a tablet version of injectable Ozempic.
Glucagon-like peptide-1 (GLP-1) is inactivated in the stomach.
That's why other GLP-1 agonists...dulaglutide (Trulicity), exenatide ER (Bydureon), liraglutide (Victoza), etc...are injected.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote